Severe bullous pemphigoid after Vaxzevria COVID-19 vaccination

Timothy COWAN; Lucinda WALLMAN; Dedee MURRELL

doi:https://doi.org/10.33204/mucosa.993581

Article Details

Severe bullous pemphigoid after Vaxzevria COVID-19 vaccination

Authors:

Timothy COWAN | Lucinda WALLMAN | Dedee MURRELL

Publisher:

Doğu Karadeniz Deri ve Zührevi Hastalıklar Derneği

Main Topics:

Diseases

Journal:

Mucosa 2022 Vol.5 Issue 1, pp.27-29

Document Type:

Article

Publication Date:

5/2022

Document Language:

English

Document ID (Org No.):

2000758197

Frequency:

Tri-annual

pISSN:

2651-2750

DOI:

https://doi.org/10.33204/mucosa.993581

Keywords:

Abstract:

 

Bullous pemphigoid has been described in a small number of cases secondary to the Pfizer and Moderna COVID-19 vaccinations. This is the first reported case of bullous pemphigoid triggered by the Oxford-AstraZeneca Vaxzevria COVID-19 vaccination. His first symptoms occurred four weeks after his first dose, and were confirmed on direct immunofluorescence and with positive BP180 antibodies.

 

Pfizer ve Moderna COVID-19 aşılarına sekonder büllöz pemfigoid az sayıda olguda tanımlanmıştır. Bu,
Oxford-AstraZeneca Vaxzevria COVID-19 aşısı tarafından tetiklenen bildirilmiş ilk büllöz pemfigoid vakasıdır.
Olgunun ilk semptomları, aşının ilk dozundan dört hafta sonra ortaya çıkmış ve büllöz pemfigoid tanısı direkt
immünofloresan test ve BP180 antikor pozitifliği ile doğrulanmıştır.

Article Details

Severe bullous pemphigoid after Vaxzevria COVID-19 vaccination

Authors:

Timothy COWAN | Lucinda WALLMAN | Dedee MURRELL

Publisher:

Doğu Karadeniz Deri ve Zührevi Hastalıklar Derneği

Main Topics:

Diseases

Journal:

Mucosa 2022 Vol.5 Issue 1, pp.27-29

Document Type:

Article

Publication Date:

5/2022

Document Language:

English

Document ID (Org No.):

2000758197

Frequency:

Tri-annual

pISSN:

2651-2750

DOI:

https://doi.org/10.33204/mucosa.993581

büllöz pemfigoid

covid-19

aşı

otoimmün büllöz hastalık

Issues

Article Details

Severe bullous pemphigoid after Vaxzevria COVID-19 vaccination

Authors: Timothy COWAN | Lucinda WALLMAN | Dedee MURRELL

Publisher: Doğu Karadeniz Deri ve Zührevi Hastalıklar Derneği

Main Topics: Diseases

Journal: Mucosa 2022 Vol.5 Issue 1, pp.27-29

Document Type: Article

Publication Date: 5/2022

Document Language: English

Document ID (Org No.): 2000758197

Frequency: Tri-annual

pISSN: 2651-2750

DOI: https://doi.org/10.33204/mucosa.993581

büllöz pemfigoid

covid-19

aşı

otoimmün büllöz hastalık

Issues

Authors:

Timothy COWAN | Lucinda WALLMAN | Dedee MURRELL

Publisher:

Doğu Karadeniz Deri ve Zührevi Hastalıklar Derneği

Main Topics:

Diseases

Journal:

Mucosa 2022 Vol.5 Issue 1, pp.27-29

Document Type:

Article

Publication Date:

5/2022

Document Language:

English

Document ID (Org No.):

2000758197

Frequency:

Tri-annual

pISSN:

2651-2750

DOI:

https://doi.org/10.33204/mucosa.993581